• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Cure Ventures backs a cell therapy startup targeting Parkinson’s

cafead

Administrator
Staff member
  • cafead   Feb 29, 2024 at 07:03: PM
via Kenai Therapeutics, a San Diego-based biotechnology company, has raised $82 million to support its work developing cell therapies for nervous system disorders.

article source